Australian firm Althea enters UK medicinal cannabis market
February 13, 2019Research and Development Epidiolex, GW Pharma, Medical marijuana, NHS, UK, cannabis
Melbourne-based medicinal cannabis company Althea has become one of the first companies to enter the UK market after the British …
Janssen’s esketamine drug recommended by FDA panel for depression
February 13, 2019Research and Development, Sales and Marketing FDA, Janssen, Spravato, depression, esketamine, major depressive disorder, pharma
In a rare and welcomed development in the treatment of major depressive disorder (MDD), Janssen has announced that its esketamine …
Researchers find new type of cell membrane which causes cancer cells to explode
February 13, 2019Research and Development Cancer, FTY720, cell membranes, molecules, oncology
Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes …
Clinigen shares soar after $210m Novartis cancer drug deal
February 13, 2019Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …
Sanofi name current CMO Dr Ameet Nathwani as new Chief Digital Officer
February 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
French firm Sanofi has appointed pharma veteran Dr Ameet Nathwani to the position of Chief Digital Officer. In his new …
Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland
February 12, 2019Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma
It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …
Immuno Biotech financial chief found guilty of money laundering
February 12, 2019Manufacturing and Production David Noakes, Dawson-Ball, GcMAF, Guernsey, Immuno Biotech
Peter Edward Dawson-Ball, the financial head of the Guernsey-based firm immuno Biotech, that sold unlicensed blood product GcMAF, has been …
Keytruda + Inlyta combo beats Pfizer’s chemotherapy Sutent in renal cell carcinoma
February 12, 2019Manufacturing and Production, Research and Development Cancer, MSD, Pfizer, inlyta, keytruda, pharma, renal cell carcinoma
New data has been revealed on the efficacy of MSD’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib), showing it …
FDA to crack down on dietary supplements
February 12, 2019Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes
The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …
Gilead shares drop 4% after failure of NASH drug to meet primary endpoint
February 12, 2019Manufacturing and Production Gilead, Shares, fatty liver disease, nash, selonsertib
Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 …
Solving the drug development problem
February 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance
Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …
Vertex doubles Q4 profits, angering cystic fibrosis drug advocates in UK
February 11, 2019Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma
Despite ongoing controversy surrounding the currently stalled negotiations between Vertex and the NHS to make its cystic fibrosis (CF) drug …
Scientists identify alcoholism gene
February 11, 2019Research and Development, Sales and Marketing Alcohol misuse, alcoholism, ethanol, oregon, research
Scientists at the Oregon Health & Science University (OSHU) in Portland have identified a gene which may play a fundamental …
UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership
February 11, 2019Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma
Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …
Diet drugs supress appetite in mosquitoes, study shows
February 11, 2019Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes
Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …
33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns
February 11, 2019Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma
A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they …
Dame Sally Davis to step down as England’s CMO to become Master of Trinity College, Cambridge
February 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Professor Dame Sally Davies is set to step down from her roles as England’s Chief Medical Officer and as the …
Researchers develop new, more effective method for detection of HIV virus genomes
February 8, 2019Medical Communications, Research and Development HIV, University of Texas, pharma
A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …
Pat Smallcombe appointed chairman of J&J Consumer, EMEA
February 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Johnson & Johnson Consumer has appointed Pat Smallcombe to the position of Company Group Chairman, Europe, Middle East, Africa (EMEA). …
FDA warns over breast implant cancer risk after nine deaths confirmed
February 8, 2019Medical Communications, Research and Development Cancer, FDA, breast implants, pharma
The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
